ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CEL Celadon Pharmaceuticals Plc

61.00
1.50 (2.52%)
22 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Celadon Pharmaceuticals Plc LSE:CEL London Ordinary Share GB00BDQYGP38 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  1.50 2.52% 61.00 57.00 65.00 61.00 59.50 59.50 12,246 14:00:11
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Investment Advice 149k -7.14M -0.1082 -5.64 39.26M

Director/PDMR Shareholding (8283G)

18/05/2011 11:10am

UK Regulatory


Celadon Pharmaceuticals (LSE:CEL)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more Celadon Pharmaceuticals Charts.

TIDMCEL

RNS Number : 8283G

Caparo Energy Ltd

18 May 2011

18 May 2011

Caparo Energy Ltd

("Caparo" or the "Company")

Directors Dealings

The Company has received notification that Raigersfield Capital Limited, a company wholly owned by Mr. Philip Swatman, a Non-executive Director of the Company, and members of his family, yesterday acquired 10,000 ordinary shares of no par value in the Company ("Ordinary Shares") at a price of 98.5 per Ordinary Share. Following this acquisition, Mr. Swatman now has a beneficial interest in 10,000 Ordinary Shares representing 0.006 per cent. of the total issued share capital of the Company.

For further information please contact:

 
 Caparo Energy Limited 
 Ravi Kailas, Chief Executive Officer             +91 40 4396 0000 
 
 Strand Hanson Limited 
 Angela Peace / Paul Cocker / James Harris    +44 (0) 20 7409 3494 
 
 Mirabaud Securities LLP 
 Peter Krens / Rory Scott                     +44 (0) 20 7878 3360 
 
 Pelham Bell Pottinger 
 Charles Vivian / Philippe Polman             +44 (0) 20 7861 3232 
 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSSFAFSAFFSESI

1 Year Celadon Pharmaceuticals Chart

1 Year Celadon Pharmaceuticals Chart

1 Month Celadon Pharmaceuticals Chart

1 Month Celadon Pharmaceuticals Chart

Your Recent History

Delayed Upgrade Clock